Search

You searched for "examination"

2689 results found

In conversation with Professor Valentina Parma, Head of GCCR

1 July 2021 | | ENTA - Rhinology / Sinus
Smell has long been regarded as the Cinderella of the senses, oft neglected by clinicians, the research community and lay public. The Global Consortium for Chemosensory Research looks to change all that. Our roving reporter, Abigail Walker, talks to its...

In conversation: Russell Tyler

6 October 2022
Alex Griffiths-Brown talks to a star of classical music about playing with a cochlear implant.

Welcome to ERS2023

10 March 2023 | | ENTA - Rhinology / Sinus
For ERS2023, for the first time, the ERS board elected a scientific president to chair the scientific programme committee. The ERS board is very happy that Prof Paolo Castlenuovo was willing to take this task upon himself. Here he outlines...

Audiology Assistant Apprenticeship – employer and apprentice perspectives

4 May 2021 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic
To celebrate National Apprenticeship week in February 2021, Keiran Joseph interviewed Caroline Jackson, Principal Audiologist at Children and Young Peoples Audiology Centre St Thomas Hospital, and Audiology Assistant Apprentice, Rachael Allan, about the value of the apprenticeship scheme in their...

Liquid gold – platelet-rich plasma glottic injections in vocal pathology

3 July 2026 | | ENTA - Laryngology / Swallowing / Voice
Platelet-rich plasma (PRP) is being used in an increasing number of ENT conditions, with particular promise in the larynx. Voice is a defining human characteristic. The ability to communicate with one another and to use the vocal folds (VFs) for...

Patron saints of the ear

2 March 2022 | | ENTA - Audiology - Adult, ENTA - Otology
We all know that ear symptoms include hearing loss, vertigo, tinnitus and otalgia, but did you know there are patron saints for all these symptoms? John Riddington Young shares an overview of the patron saints of the ear, inspired by...

Genomic testing for deafness and its implications

2 September 2022 | | ENTA - Audiology - Diagnostic, ENTA - Audiology - Adult, ENTA - Otology
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Music is noise

1 July 2018 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric
Marshall Chasin recaps what we know acoustically about music and noise, and discusses the potentially damaging levels of music, how temporary threshold shift (TTS) is not necessarily temporary and gives us some considerations for protective devices for musicians. Most of...

The MACRO Trial: defining best management of chronic rhinosinusitis

7 January 2026 | | ENTA - Rhinology / Sinus
A major UK trial in The Lancet finds ESS provides greater symptom relief than long-term macrolides for adults with CRS, supporting earlier surgery and fewer antibiotics. The MACRO Programme was established in 2016 when the UK National Institute of Health...

Patient experience of necrotising otitis externa

2 March 2022 | | ENTA - Otology
Necrotising otitis externa is increasing in incidence in the UK and becoming a rising burden to patients and health services. Despite a growing body of literature on this condition, we know very little about patient experience of necrotising otitis externa....

Beyond hearing aids: early interventions in hearing care to lower dementia risk

6 November 2024 | | ENTA - Audiology - Adult
Published in print under the titleHearing care and dementia: professional insights on the new Lancet Commission findingsThe Lancet Commission on ‘Dementia prevention, intervention and care: 2024 report’ highlights a list of potential modifiable factors to reduce dementia risk. As with...

FDA Approved Lenire Expands Number of US Clinics

1 March 2024 | Company Profiles, Contracts & Distributors, Research & Development
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.